Sequencing SARS-CoV-2 genome

Researchers at the Instituto Gulbenkian de Ciência (IGC) started sequencing samples of the SARS-CoV-2 virus provided by hospital units in the Lisbon region. The samples are sequenced and compared with other genomes of the virus. 

Knowing the virus and its potential mutations is fundamental to set containment, treatment and prevention strategies. The data will be added to open access platforms that allow all scientific community to share this information. 


New lines of Research

Several teams at the IGC redirected part of their research with the aim of knowing more about the new coronavirus. These new studies focus on the virology and evolution fields as well as in the immunology and tolerance to infection subjects.

These projects will allow us to expand knowledge about mutation rates of the virus, on how it replicates, and also on the tolerance to infection, allowing us to evaluate the effectiveness of medicines already available in the market and open the way for new therapies.

Updated on 03 february 2021

Cookies settings

Cookies Selection

The Calouste Gulbenkian Foundation uses cookies to improve your browsing experience, security, and its website performance. The Foundation may also use cookies to share information on social media and to display messages and advertisements personalised to your interests, both on our website and in others.